Long-term 14-year survival with primary hepatic angiosarcoma

BMJ Case Rep. 2022 Aug 10;15(8):e250856. doi: 10.1136/bcr-2022-250856.

Abstract

Primary hepatic angiosarcomas (PHAs) are rare primary liver malignancies with poor outcomes due to their aggressive nature and the difficulty it presents in terms of diagnosis and management. However, early diagnosis and aggressive surgical resection combined with ongoing surveillance can confer prolonged survival in patients with PHA. Additionally, adjuvant radiotherapy may be of benefit in cases of involved surgical margins. Here we report the longest surviving patient with PHA in literature to date. The patient had an initial right hemihepatectomy 14 years ago and 10 years later had a segment III segmentectomy for recurrence on surveillance imaging. This was followed with adjuvant radiotherapy for involved margins. There has been no further recurrence noted on imaging to date, and the patient is continuing to thrive in the community.

Keywords: General surgery; Hepatic cancer; Surgery.

Publication types

  • Case Reports

MeSH terms

  • Hemangiosarcoma* / diagnostic imaging
  • Hemangiosarcoma* / surgery
  • Hepatectomy
  • Humans
  • Liver Neoplasms* / pathology
  • Margins of Excision
  • Mastectomy, Segmental